PDS Biotechnology Corp
Developing T-cell activating immunotherapies for cancer and infectious diseases.
PDSB | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 303A COLLEGE ROAD EAST, 8540 PRINCETON
- Website:
- https://www.pdsbiotech.com
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
PDS Biotechnology Corp. is a clinical-stage immunotherapy company developing a pipeline of treatments for various cancers and infectious diseases. The company's proprietary Versamune® platform is designed to harness the body's immune system by activating a potent and targeted T-cell attack against diseased cells. The technology aims to overcome tumor defense mechanisms by delivering immune-stimulating agents directly into the tumor microenvironment, inducing a robust and durable response. PDS Biotech's pipeline includes investigational therapies for cancers such as head and neck, prostate, breast, and cervical cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PDS Biotechnology Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PDS Biotechnology Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PDS Biotechnology Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
